Concepedia

LBA26 BREAKWATER safety lead-in (SLI): Encorafenib (E) + cetuximab (C) + chemotherapy (chemo) for BRAFV600E metastatic colorectal cancer (mCRC)

Josep Tabernero, T. Yoshino, T.W. Kim, R. Yaeger, J. Desai, Harpreet Wasan, Eric Van Cutsem, Fortunato Ciardiello, Tim Maughan, C. Eng,

Annals of Oncology · 2022 · 13 citations · 0 references

DOI

Concepts